See also this year's filing and all EDGAR filings for this company.
PDF Report 0001269021_2020_Portola_Pharmaceuticals_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001269021, Portola Pharmaceuticals INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 462,133,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 4,264,000 |
| 3 | remainder_Assets | 112,086,000 |
| 4 | LiabilitiesCurrent | 102,418,000 |
| 5 | LiabilitiesNoncurrent | 135,183,000 |
| 6 | remainder_Liabilities | 211,057,000 |
| 7 | CostOfGoodsAndServicesSold | 175,624,540 |
| 8 | SellingGeneralAndAdministrativeExpense | 542,752,125 |
| 9 | ResearchAndDevelopmentExpense | 139,636,668 |
| 10 | remainder_Expenses | 73,541,369 |
| 11 | remainder_Revenues | 498,801,225 |
| 12 | remainder_NetIncome | 10,463,282 |
| 13 | remainder_ComprehensiveNetIncome | 12,922,167 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 578,483,000 |
| 1 | Liabilities | 448,658,000 |
| 2 | Expenses | 931,554,702 |
| 3 | Revenues | 498,801,225 |
| 4 | StockholdersEquity | 129,825,000 |
| 5 | NetIncome | -422,290,195 |
| 6 | ComprehensiveNetIncome | -415,829,112 |
| 7 | BaseVar | 1,240,441,188 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.259 |
| 9 | EconomicCapitalRatio | 1.40 |
Edgar->Model Mapping
Feature Distribution
Change over Time
